CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Zhejiang Jingxin Pharmaceutical Co., Ltd is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Zhejiang Jingxin Pharmaceutical Co., Ltd
No. 800
Xinchang Avenue East Road,Yulin Street
Phone: +86 57586176531p:+86 57586176531 SHAOXING, ZHJ  312500  China Ticker: 002020002020
Business Summary
Zhejiang Jingxin Pharmaceutical Co Ltd is a China-based company principally engaged in pharmaceutical manufacturing. The Company operates four segments. The Finished Drug business segment is engaged in the production and sales of preparations such as Kangfuxinye, Bacillus licheniformis Live Bacteria Capsules, Simvastatin Tablets, Rosuvastatin Calcium Tablets, Pivastatin Calcium Dispersible Tablets, and Sertraline Hydrochloride Tablets. The Active Pharmaceutical Ingredients (APIs) Business segment is engaged in the production and sale of quinolones, statins, and psychoneurotic APIs. The Medical Device Business segment is engaged in the research and development, production and sales of medical-specific displays, and provides full-process services from pre-sale research and development to after-sale maintenance, main products including customized medical display products and standardized medical display products. Other Business segment is engaged in real estate rental business.

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
YesYes-----

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
3/31/202512/31/2024Yes----

Industries
SIC Code Description
2833 Medicinal chemicals and botanical products
2834 Pharmaceutical preparations
3841 Surgical and medical instruments and apparatus
6512 Operators of nonresidential buildings

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Chairman of the Board, President GangLu 60 7/21/2023
Vice Chairman of the Board NengnengWang 49 1/1/2021 11/29/2008
Chief Financial Officer, Vice President, Director MeiliChen 53 3/28/2023 10/9/2010
10 additional Officers and Directors records available in full report.

Subsidiaries
Business Name Address City State/Province Country
Shenzhen Beacon Display Technology Co., Ltd. 12F, Block B1, Nanshan Zhiyuan Nanshan District Shenzenn China

Business Names
Business Name
002020
Shenzhen Beacon Display Technology Co., Ltd.
Zhejiang Jingxin Pharmaceutical Co., Ltd

General Information
Number of Employees: 3,869 (As of 12/31/2024)
Outstanding Shares: 861,029,140 (As of 3/31/2025)
Shareholders: 28,060
Stock Exchange: SHE
Fax Number: +86 57586096898


Copyright © 2025 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Tuesday, May 13, 2025